Orange is one of the world’s leading telecommunications operators with sales of 41 billion euros in 2018 and 151,000 employees worldwide at 31 December 2018, including 92,000 employees in France. The Group has a total customer base of 264 million customers worldwide at 31 December 2018, including 204 million mobile customers and 20 million fixed broadband customers. The Group is present in 27 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies, under the brand Orange Business Services.
In addition to reshaping societies, digital technology is opening up new growth opportunities for Orange. The overarching aim of the company is to build a more intelligent, more open and more responsible society. That involves rising to the challenges that the digital revolution is bringing about, i.e. harnessing innovation to make it useful and make sure its benefits reach as many people as possible.
Gavi and Orange Middle East and Africa recognise the importance of mobile health solutions to improve the efficiency of national health systems, especially in reaching the millions of children who continue to miss out on life-saving vaccines that protect them for life.
Gavi and Orange SA signed a letter of intent in 2017 to explore ways to collaborate to assist Gavi-supported countries to reinforce the interface between local communities and health facilities, leading to improvement in the quality of health services and as a consequence, to increase immunisation coverage, reduce vaccine wastage, increase efficiency and better ensure vaccine potency.
For more information about Orange, please visit https://healthcare.orange.com/en/
Contributions and pledges in total:
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2018 and Q1-Q3 2019, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2019, IFFIm donor grant payments are reduced by 1.5%, however such reductions are not reflected in future contributions figures.